China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China. Latest news

Currently available polymerase chain reaction (PCR) tests can detect the emerging Omicron variant of the virus that causes COVID-19, according to the World Health Organization.

The European Union's in vitro diagnostic expert panel has published its first opinion on an In Vitro Diagnostic Medical Devices Regulation (IVDR) submission, delivering a glowing opinion of the filing for a test to screen plasma donor samples for hepatitis E virus (HEV).

The world is in a "race against time" with the Omicron coronavirus variant, said European Commission President Ursula von der Leyen on Sunday, warning during a visit to Latvia that scientists and manufacturers will need weeks to fully understand the new variant.

In order to promote the expansion of high-quality medical resources and balanced regional layout, local governments give full financial support on construction of public hospitals.

One of the first jobs the US Food and Drug Administration’s new inspections council will take on is developing policy around the agency’s use of Remote Regulatory Assessments.

Most human diseases can be traced to malfunctioning parts of a cell — a tumor is able to grow because a gene wasn’t accurately translated into a particular protein or a metabolic disease arises because mitochondria aren’t firing properly, for example.

South Korean diagnostics firm NGeneBio said on Tuesday that it has received CE-IVD marking for its next-generation sequencing-based human leukocyte antigen (HLA) typing assay.

South Korean diagnostics firm NGeneBio said on Tuesday that it has received CE-IVD marking for its next-generation sequencing-based human leukocyte antigen (HLA) typing assay.

Pascal Soriot, the executive director and chief executive officer of AstraZeneca, recently featured on the BBC Radio 4's The Today Program. He was pressed to respond to the notion of mRNA vaccines – such as the Pfizer–BioNTech COVID-19 vaccine – becoming the "future" of vaccinology.

Beckman Coulter Life Sciences announced on Monday that it has inked an application development agreement with Integrated DNA Technologies for its forthcoming Biomek NGenius next-generation library preparation system.